Establishment of patient-derived cancer organoids for drug-screening applications

Else Driehuis; Kai Kretzschmar; Hans Clevers

doi:10.1038/s41596-020-0379-4

Related publications

Corrigendum2021

Author Correction: Establishment of patient-derived cancer organoids for drug-screening applications

Else Driehuis, Kai Kretzschmar, Hans Clevers

Article2016

Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

Carla S. Verissimo, Rene Overmeer, Bas Ponsioen, Jarno Drost, Sander Mertens, Ingrid Verlaan-Klink, Bastiaan van Gerwen, Marieke van der Ven, Marianne D. van de Wetering, David A. Egan, René Bernards, Hans Clevers, Johannes L. Bos, Hugo J.G. Snippert

Article2021

Medium-Throughput Drug- and Radiotherapy Screening Assay using Patient-Derived Organoids

Marrit Putker, Rosemary Millen, Rene Overmeer, Else Driehuis, Maurice M.J.M. Zandvliet, Hans Clevers, Sylvia F. Boj, Qi‐Xiang Li

Preprint2016

Author response: Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening

Carla S. Verissimo, Rene Overmeer, Bas Ponsioen, Jarno Drost, Sander Mertens, Ingrid Verlaan-Klink, Bastiaan van Gerwen, Marieke van der Ven, Marc van de Wetering, David A. Egan, René Bernards, Hans Clevers, Johannes L. Bos, Hugo J.G. Snippert

Article2021

Drug Repurposing Screen on Patient-Derived Organoids Identifies New Therapeutic Drug Combination Against KRAS Mutant Colon Cancer

Sander Mertens, Carla S. Verissimo, Bas Ponsioen, Maarten A. Huismans, Jeanine Roodhart, Maarten A. Huismans, Rene Overmeer, Natalie Proost, Olaf Van Tellingen, Marieke van de Ven, Harry Begthel, Sylvia F. Boj, Hans Clevers, Jeanine Roodhart, Johannes L. Bos, Hugo J.G. Snippert